Overview & Value Proposition:

For more than 20 years, we have harnessed the most successful, progressive practices from across our community network, creating baselines for performance through the G&A benchmark data. We have had 160 unique companies participate in our studies with a balance of large biopharmaceuticals and medical device / consumer, mid-tier, and smaller organizations that are scaling. The power of our information allows us to provide sophisticated peer data for a variety of strategic matters including:

We expanded our client offerings in 2019, by starting a Membership Program that combines survey participation with our strategic advisory service and access to our private content through our Executive Lounge. Members gain access to this data along with tailored 1:1 briefings, a steady stream of private events including our KPI/Metrics Forum, additional research and analyses, and expert insights through podcast and custom content.